RT Journal Article
SR Electronic
T1 Assessing suppression strategies against epidemic outbreaks like COVID-19: the SPQEIR model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.22.20075804
DO 10.1101/2020.04.22.20075804
A1 Proverbio, Daniele
A1 Kemp, Françoise
A1 Magni, Stefano
A1 Husch, Andreas
A1 Aalto, Atte
A1 Mombaerts, Laurent
A1 Skupin, Alexander
A1 Gonçalves, Jorge
A1 Ameijeiras-Alonso, Jose
A1 Ley, Christophe
YR 2020
UL http://medrxiv.org/content/early/2020/05/02/2020.04.22.20075804.abstract
AB Background The current COVID-19 outbreak represents a most serious challenge for societies worldwide. It is endangering the health of millions of people, and resulting in severe socioeconomic challenges due to lock-down measures. Governments worldwide aim to devise exit strategies to revive the economy while keeping the pandemic under control. The problem is that the effects of distinct measures are not well quantified.Methods This paper compares several suppression approaches and potential exit strategies extending the classic epidemic SEIR model into a SPQEIR model. This allows to assess the effect of individual and combined approaches on epidemic decline. In addition to peak flattening, we also estimate the time to zero infectious associated with each strategy, and their corresponding reproduction number. Finally, the paper provides an online tool that allows researchers and decision makers to interactively simulate diverse scenarios with our model.Findings While rapid and strong lock-down is an effective pandemic suppression measure, a combination of other strategies such as social distancing, active protection and removal can achieve similar suppression synergistically. Strength and type of intervention measures matter to achieve effective and rapid epidemic suppression.Interpretation Pursuing one intervention strategy alone requires its full enhancement. On the contrary, aiming at synergistic scenarios could impact epidemic decline with analogous effect and timing, with milder individual effort. This quantitative understanding can support the establishment of midand long-term interventions, in particular towards phase 2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDP and SM's work is supported by the FNR PRIDE DTU CriTiCS, ref 10907093. FK’s work is supported by the Luxembourg National Research Fund PRIDE17/12244779/PARK-QC. A.H. work was partially supported by the Fondation Cancer Luxembourg. JG is partly supported by the 111 Project on Computational Intelligence and Intelligent Control, ref B18024. AA is supported by the Luxembourg National Research Fund (FNR) (Project code: 13684479). JAA is supported by the FWO research project G.0826.15N (Flemish Science Foundation), GOA/12/014 project (Research Fund KU Leuven), Project MTM2016-76969-P from the Spanish State Research Agency (AEI) co-funded by the European Regional Development Fund (ERDF) and the Competitive Reference Groups 2017-2020 (ED431C 2017/38) from the Xunta de Galicia through the ERDF.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data are used. Simulation code is publicly available. https://github.com/daniele-proverbio/Covid-19